The AD Tx Revolution at ACAAI
Dermatology Times
NOVEMBER 20, 2023
Andrew F. Alexis, MD, MPH, shared insights into using JAK inhibitors as part of the treatment revolution in atopic dermatitis at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.
Let's personalize your content